Sickle cell disease and anesthesia
PG Firth, CA Head, DC Warltier - … Journal of the American Society of …, 2004 - pubs.asahq.org
IN October 1902, a “peculiar anomaly in human red blood corpuscles... came to notice in the
histologic laboratory of the Ohio State University,” Columbus, Ohio.“Examination disclosed …
histologic laboratory of the Ohio State University,” Columbus, Ohio.“Examination disclosed …
Current issues with blood transfusions in sickle cell disease
EP Vichinsky - Seminars in hematology, 2001 - Elsevier
With increased recognition of the profound morbidity of sickle cell disease and with growing
evidence of the efficacy of transfusion therapy in prevention and treatment of sickle cell …
evidence of the efficacy of transfusion therapy in prevention and treatment of sickle cell …
Prospective RBC phenotype matching in a stroke‐prevention trial in sickle cell anemia: a multicenter transfusion trial
EP Vichinsky, NLC Luban, E Wright, N Olivieri… - …, 2001 - Wiley Online Library
BACKGROUND: Most sickle cell anemia patients undergo transfusion therapy to prevent
complications. The Stroke Prevention Trial in Sickle Cell Anemia showed that transfusion …
complications. The Stroke Prevention Trial in Sickle Cell Anemia showed that transfusion …
[HTML][HTML] Alloimmunization in thalassemia patients: New insight for healthcare
A Davoudi-Kiakalayeh, R Mohammadi… - … journal of preventive …, 2017 - journals.lww.com
Background: Development of alloantibodies against the foreign red blood cell (RBC)(
alloimmunization) is a well-known complication in thalassemia patients when performing …
alloimmunization) is a well-known complication in thalassemia patients when performing …
Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases
H Schonewille, HL Haak, AM Van Zijl - Transfusion, 1999 - Wiley Online Library
BACKGROUND: Because of intensive marrow depression and improved survival, patients
with hematologic and oncologic malignancies are dependent on transfusion for a longer …
with hematologic and oncologic malignancies are dependent on transfusion for a longer …
Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
H Schonewille, LMG Van De Watering, A Brand - Transfusion, 2006 - Wiley Online Library
BACKGROUND: Red blood cell (RBC) alloimmunization is common in transfused patients.
Most studies report on the rate of alloimmunization in chronically transfused patients, which …
Most studies report on the rate of alloimmunization in chronically transfused patients, which …
[HTML][HTML] Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients
Background: The development of anti-red blood cell antibodies (both allo-and
autoantibodies) remains a major problem in thalassemia major patients. We studied the …
autoantibodies) remains a major problem in thalassemia major patients. We studied the …
Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells
JE Hendrickson, TE Chadwick… - Blood, The Journal …, 2007 - ashpublications.org
Factors regulating which patients become alloimmunized to red blood cell (RBC) antigens
are poorly understood. Using a murine model of transfusion, we recently reported that viral …
are poorly understood. Using a murine model of transfusion, we recently reported that viral …
[HTML][HTML] Global burden of transfusion in sickle cell disease
BPD Inusa, W Atoyebi, B Andemariam… - … and Apheresis Science, 2023 - Elsevier
Sickle cell disease (SCD) is the most common hereditary hemoglobinopathy. The underlying
pathophysiology of the red blood cell (RBC) leads to pan-systemic complications which …
pathophysiology of the red blood cell (RBC) leads to pan-systemic complications which …
Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival
MJ Telen, A Afenyi‐Annan, ME Garrett… - …, 2015 - Wiley Online Library
Background Alloimmunization remains a significant complication of transfusion and has
been associated with multiple factors, including inflammation, an important pathophysiologic …
been associated with multiple factors, including inflammation, an important pathophysiologic …